An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients. [PDF]
Goi N +4 more
europepmc +1 more source
Mapping Lysosomal Storage Disorders with Neurological Features by Cellular Pathways: Towards Precision Medicine. [PDF]
Makridou A +6 more
europepmc +1 more source
Adherence to Cysteamine Therapy Among Patients Diagnosed with Cystinosis in Saudi Arabia: A Prospective Cohort Study. [PDF]
Algasem R +7 more
europepmc +1 more source
Cortical impairment and reduced muscle mass in children and young adults with nephropathic cystinosis. [PDF]
Bechtold-Dalla Pozza S +6 more
europepmc +1 more source
Let Food Be Thy Medicine: Potential of Dietary Management in Cystinosis.
Levtchenko E, Arcolino FO.
europepmc +1 more source
Multimodal imaging of infantile nephropathic cystinosis
Cystinosis is a lysosomal storage disorder characterized by cystine crystal accumulation in different parts of body including the eyes. The purpose of this article was to describe different ophthalmological abnormalities in cystinosis using multimodal ...
K. Roy +3 more
semanticscholar +2 more sources
Related searches:
Corneal Manifestation in Patients with Infantile Nephropathic Cystinosis
Klinische Monatsblätter für Augenheilkunde, 2022Nephropathic cystinosis is a rare autosomal recessive disease caused by mutations in the CTNS gene. This causes dysfunction of cystinosin, a protein that transports cystine out of lysosomes, causing cystine crystals to accumulate in cells in most organ ...
F. Kruse +4 more
semanticscholar +3 more sources
Posterior Segment Involvement in Infantile Nephropathic Cystinosis – A Review
Klinische Monatsblätter für Augenheilkunde, 2022Cystinosis is a rare lysosomal storage disease with a prevalence of 1 : 100 000 – 1 : 200 000 cases. It is caused by biallelic mutations in the CTNS gene, which encodes cystinosin, that transport cystine out of the lysosomes.
L. Keidel +6 more
semanticscholar +3 more sources

